Consolidated Statements of Earnings - USD ($) shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Mar. 31, 2018	Mar. 31, 2017	Mar. 31, 2018	Mar. 31, 2017
Revenue	$ 33,633	$ 31,821	$ 101,460	$ 97,010
Cost of products sold	31,720	30,093	96,014	92,089
Gross margin	1,913	1,728	5,446	4,921
Operating expenses:
Distribution, selling, general and administrative expenses	1,132	960	3,325	2,792
Restructuring and employee severance	2	15	155	31
Amortization and other acquisition-related costs	175	128	543	365
Impairments and (gain)/loss on disposal of assets, net	(6)	2	62	15
Litigation (recoveries)/charges, net	64	18	155	37
Operating earnings	546	605	1,206	1,681
Other (income)/expense, net	(2)	(5)	(6)	(2)
Interest expense, net	84	46	251	134
Loss on Extinguishment of Debt	0	0	2	0
Earnings before income taxes	464	564	959	1,549
Provision for/(benefit from) income taxes	209	182	(466)	533
Net earnings	255	382	1,425	1,016
Net earnings attributable to noncontrolling interests	0	(1)	(3)	(2)
Net earnings attributable to Cardinal Health, Inc.	$ 255	$ 381	$ 1,422	$ 1,014
Earnings per common share attributable to Cardinal Health, Inc.:
Basic (in shares)	$ 0.81	$ 1.21	$ 4.52	$ 3.19
Diluted (in shares)	$ 0.81	$ 1.20	$ 4.50	$ 3.17
Weighted-average number of common shares outstanding:
Basic (in shares)	313	316	314	318
Diluted (in shares)	315	318	316	320
Cash dividends declared per common share	$ 0.4624	$ 0.4489	$ 1.3872	$ 1.3467